EUVIMEDEUVIMED entdecken
Crossref

Predictive Value of Systemic Inflammatory Markers in the Prognosis of Prostate Cancer with Variant Histology.

Huseyin Aytac Ates, Semih Aktas, Muhammet Hilmi Enes Araci, Emrah Okucu, Berrin Yalcin, Hikmet Koseoglu

Urology journal./Urology jornal. · 08.10.2025 · 22 (4) · 187-192

DOI: 10.22037/uj.v22i.8378 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Urology journal./Urology jornal., erschienen am 08.10.2025. Verfasst von Huseyin Aytac Ates und 5 weiteren Autor:innen. Beteiligte Einrichtung: Health Sciences University, Istanbul Training and Research Hospital,Department of Urology, ,Istanbul, ,Turkiye. h.aytacates@gmail.com. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Adenocarcinoma, Inflammation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: This study aimed to investigate the potential role of systemic inflammatory markers in the management of Prostate Cancer (PCA) with variant pathology. MATERIALS AND METHODS: A retrospective analysis was conducted on 302 patients who underwent radical prostatectomy between 2014 and 2023. After applying exclusion criteria, 279 patients were included: 207 with adenocarcinoma and 72 with variant pathologies. Systemic inflammatory markers such as Neutrophil-to-Lymphocyte Ratio (NLR), Platelet-to-Lymphocyte Ratio (PLR), Systemic Immune-Inflammation Index (SII), and Systemic Inflammation Response Index (SIRI) were compared between the groups. RESULTS: Patients in the variant group were significantly older (p = 0.005). The frequencies of lymphovascular invasion (LVI), perineural invasion (PNI), and positive surgical margins (SM) were significantly higher in the variant histology group (p < 0.001, p = 0.014, and p < 0.001, respectively), as were ISUP grades (p < 0.001). Pretreatment PSA values were also significantly higher in the variant group (p < 0.001), as was the rate of subsequent radiotherapy (p < 0.001). However, no significant differences were found in NLR, PLR, SIRI, or SII values between the groups. Recurrence rates were significantly higher in the variant group (p < 0.05), but overall mortality did not differ. CONCLUSION: Systemic inflammation markers have limited value in predicting prognosis among patients with variant PCA. This highlights the complex role of inflammation in cancer progression and underscores the need for further research to identify more specific biomarkers for different PCA variants.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prostatic NeoplasmsAdenocarcinomaInflammationHumansMaleRetrospective StudiesMiddle AgedAgedPrognosisProstatectomyPredictive Value of TestsNeutrophilsBiomarkers, TumorLymphocytesNeoplasm Invasiveness

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • Health Sciences University, Istanbul Training and Research Hospital,Department of Urology, ,Istanbul, ,Turkiye. h.aytacates@gmail.com.
  • Health Sciences University, Istanbul Training and Research Hospital,Department of Urology, ,Istanbul, ,Turkiye. semihaktas077@gmail.com.
  • Health Sciences University, Istanbul Training and Research Hospital,Department of Urology, ,Istanbul, ,Turkiye. araci.enes96@gmail.com.
  • Health Sciences University, Istanbul Training and Research Hospital,Department of Urology, ,Istanbul, ,Turkiye. dremrahokucu@gmail.com.
  • Health Sciences University, Istanbul Training and Research Hospital,Department of Radiation Oncology, Istanbul, ,Turkiye . byalcin77@hotmail.com.
  • Health Sciences University, Istanbul Training and Research Hospital,Department of Urology, ,Istanbul, ,Turkiye. hikmet.koseoglu@gmail.com.

Zitieren

APA

Ates, H. A., Aktas, S., Araci, M. H. E., Okucu, E., Yalcin, B., & Koseoglu, H. (2025). Predictive Value of Systemic Inflammatory Markers in the Prognosis of Prostate Cancer with Variant Histology. Urology journal./Urology jornal., 22(4), 187-192. https://doi.org/10.22037/uj.v22i.8378

Vancouver

Ates HA, Aktas S, Araci MHE, Okucu E, Yalcin B, Koseoglu H. Predictive Value of Systemic Inflammatory Markers in the Prognosis of Prostate Cancer with Variant Histology. Urology journal./Urology jornal.. 2025;22(4):187-192. doi:10.22037/uj.v22i.8378

BibTeX
@article{Ates2025,
  author = {Ates, Huseyin Aytac and Aktas, Semih and Araci, Muhammet Hilmi Enes and Okucu, Emrah and Yalcin, Berrin and Koseoglu, Hikmet},
  title = {Predictive Value of Systemic Inflammatory Markers in the Prognosis of Prostate Cancer with Variant Histology},
  journal = {Urology journal./Urology jornal.},
  year = {2025},
  volume = {22},
  number = {4},
  pages = {187--192},
  doi = {10.22037/uj.v22i.8378}
}
Kostenlos starten →